Get started

Financials · COSM

Cosmos Health Inc. (COSM) financials

For the twelve months ended Jun 30, 2026, Cosmos Health Inc. reported $73.73M of revenue and -$24.39M of net income.

Revenue, TTM
$73.73M
Revenue growth, YoY
+33.8%
Net income, TTM
-$24.39M
Net margin
-33.1%
Free cash flow, TTM
-$9.93M
EPS, diluted, TTM
-$0.66
Cash
$1.80M
Total debt
$1.88M
P/S
0.41
Market cap
$30.2M
Annual revenue$65.27M
FY2016FY2025
Annual net income-$19.14M
FY2016FY2025
Annual free cash flow-$8.50M
FY2016FY2025

COSM revenue and earnings growth

COSM revenueQ2 2026$18.99M

Quarter YoY
+28.8%
QoQ
+5.9%
FY YoY
+19.9%
5Y CAGR
+3.3%
10Y CAGR
+61.7%

COSM revenue was $18.99M in fiscal Q2 2026 (ended Jun 30, 2026), up 28.8% from a year earlier and up 5.9% from the prior quarter. For the full fiscal 2025 it was $65.27M, up 19.9% from fiscal 2024. Compound annual growth was +3.3% over 5 years and +61.7% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 13 fiscal years on file.

COSM net incomeQ2 2026-$6.09M

COSM net income was -$6.09M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$2.83M a year earlier. For the full fiscal 2025 it was -$19.14M, compared with -$16.18M in fiscal 2024.

COSM EPSQ2 2026-$0.10

COSM diluted EPS was -$0.10 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$0.63.

COSM free cash flowQ2 2026-$1.78M

COSM free cash flow was -$1.78M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$1.23M a year earlier. For the full fiscal 2025 it was -$8.50M, compared with -$8.14M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$65.27M$54.43M$53.38M$50.35M$56.24M$55.41M$39.68M$37.08M$30.01M$6.76M
Cost of revenue$57.38M$50.12M$49.03M$44.39M$47.91M$47.35M$36.01M$34.68M$28.06M$6.15M
Gross profit$7.90M$4.31M$4.35M$5.96M$8.33M$8.06M$3.66M$2.41M$1.96M$601.0K
Research and development$519.4K$533.3K$164.9K-------
Selling, general and admin$15.62M$11.73M$19.64M$10.18M$9.21M$2.10M$3.29M$3.59M$4.85M$794.1K
Operating income-$16.70M-$15.54M-$21.83M-$7.47M-$4.53M$2.71M-$255.8K-$1.23M-$4.87M-$202.5K
Interest expense$1.90M$1.01M$866.5K$2.35M$2.82M$2.76M-$1.41M-$967.8K$748.5K$189.7K
Pre-tax income-$19.14M-$16.18M-$18.54M-$13.06M-$7.85M$1.20M-$3.12M-$9.04M-$6.21M-$600.2K
Income tax$0$0$0-$775.1K$114.0K-$377.5K$182.8K-$17.3K$2.8K$769
Net income-$19.14M-$16.18M-$18.54M-$13.83M-$7.96M$820.8K-$3.30M-$9.06M-$6.21M-$601.0K
EPS, basic-$0.63-$1.17-$2.15-$33.16-$23.74$1.50-$6.25-$17.00-$12.25-$1.25
EPS, diluted-$0.63-$1.17-$2.15-$33.16-$23.74$1.50-$6.25-$17.00-$12.25$2018525.00
Diluted shares30.3M19.1M-1.9M656,933532,311.76530,943.84532,264.48511,200.52502,592.96

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$715.7K$315.1K$3.83M$20.75M$286.5K$628.4K$38.5K$864.3K$782.9K$716.6K
Short-term investments$46.2K$21.1K$20.1K$14.9K$11.5K$222.8K$238.9K$2.71M--
Receivables$19.63M$13.48M$19.76M$23.69M---$4.75M$1.26M$661.9K
Inventory$5.78M$4.36M$4.79M$3.45M$3.15M$3.29M$3.47M$3.20M--
Current assets$38.39M$25.46M$36.61M$56.37M$39.83M$40.77M$21.18M$18.35M$9.51M$2.64M
Goodwill$49.7K$49.7K$49.7K$49.7K$49.7K$49.7K$49.7K$49.7K$1.95M-
Total assets$65.48M$54.31M$66.01M$68.04M$49.43M$43.84M$23.88M$20.69M$10.68M$3.12M
Current liabilities$38.27M$25.76M$24.32M$21.75M$29.93M$34.29M$28.24M$22.27M$13.70M$4.87M
Short-term debt--$1.91M-------
Long-term debt$4.27M$0$1.33M-$477.6K-----
Total debt$4.27M$0$3.24M$5.02M$477.6K$10.77M$0$145.5K--
Total liabilities$47.05M$29.78M$29.97M$28.38M$45.05M$48.01M$30.34M$24.01M$13.70M$4.87M
Shareholders' equity$18.42M$24.53M$36.04M$39.28M$4.38M-$4.16M-$6.46M-$3.32M-$3.03M-$1.75M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$8.45M-$7.72M-$15.64M-$14.87M-$7.10M-$11.50M-$4.79M-$1.56M-$8.76M-$2.13M
Capital expenditures$55.7K$418.1K$1.31M$74.2K$581.4K$117.7K-$503.4K$55.3K$12.8K
Free cash flow-$8.50M-$8.14M-$16.95M-$14.94M-$7.68M-$11.62M--$2.06M-$8.82M-$2.14M
Investing cash flow-$2.01M-$798.3K-$13.76M-$21.5K-$826.8K-$117.7K$588.9K-$195.8K-$14.5K-$144.7K
Financing cash flow$14.06M$5.05M$12.69M$35.05M$7.27M$12.46M$3.59M$1.99M$9.29M$2.74M
Share repurchases-$0$100.5K-$376.9K$200.0K----
Stock-based compensation$2.31M$1.69M$577.9K$24.4K$5.90M--$242.0K$338.8K$16.6K
Depreciation and amortization$1.36M$1.22M$614.4K$188.9K$352.4K$397.6K$394.6K$43.9K--

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY19.9%2.0%6.0%-10.5%1.5%39.6%7.0%23.6%344.3%1165.5%
Gross margin12.1%7.9%8.1%11.8%14.8%14.5%9.2%6.5%6.5%8.9%
Operating margin-25.6%-28.6%-40.9%-14.8%-8.1%4.9%-0.6%-3.3%-16.2%-3.0%
Net margin-29.3%-29.7%-34.7%-27.5%-14.2%1.5%-8.3%-24.4%-20.7%-8.9%
Free cash flow margin-13.0%-14.9%-31.8%-29.7%-13.7%-21.0%--5.6%-29.4%-31.7%
Return on equity-103.9%-66.0%-51.4%-35.2%-181.8%-----
Return on assets-29.2%-29.8%-28.1%-20.3%-16.1%1.9%-13.8%-43.8%-58.2%-19.3%
Current ratio1.000.991.512.591.331.190.750.820.690.54
Debt to equity0.230.000.090.130.11-----

Source: XBRL data Cosmos Health Inc. files with the SEC, latest filing dated Aug 18, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-25, first reported Apr 12, 2023.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

COSM peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
COSM$73.73M+33.8%-$24.39M-33.1%$30.2M
MCK$418.79B+8.2%$4.70B1.1%$122.48B
COR$332.77B+5.1%$2.62B0.8%$63.65B
CAH$254.25B+14.2%$1.71B0.7%$62.92B
HLF$5.28B+6.4%$179.80M3.4%$1.60B
NUS$1.38B-15.4%-$216.39M-15.7%$199.4M
ZSTK$40.03M+27.3%-$177.84M-444.2%$55.0M
ESYN$389.7K-68.5%-$2.65M-680.2%$48.5M
MEDS$8.02M-78.2%-$88.28M-1100.3%$5.7M

COSM FAQ

9 questions
  • What is COSM revenue?
    Cosmos Health Inc. (COSM) reported $73.73M of revenue for the twelve months ended Jun 30, 2026. That is up 33.8% from the year before. Revenue for fiscal 2025 was $65.27M.
  • Is COSM profitable?
    No. Cosmos Health Inc. reported a net loss of $24.39M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does COSM have?
    Cosmos Health Inc. reported $1.80M in cash and cash equivalents and $1.88M of debt on its most recent balance sheet in SEC filings.
  • How fast is COSM revenue growing?
    Cosmos Health Inc.'s revenue changed +19.9% in fiscal 2025, to $65.27M. Its compound annual growth rate was +3.3% over 5 years and +61.7% over 10 years.
  • What is COSM gross margin?
    Cosmos Health Inc.'s gross profit was $7.57M on $73.73M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 10.3%.
  • What is COSM free cash flow?
    Cosmos Health Inc. generated -$9.93M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$9.84M less capital expenditures.
  • What is COSM earnings per share?
    Diluted earnings per share were -$0.66 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did COSM last report financial results?
    The latest statements here come from Cosmos Health Inc.'s 10-Q filed on Aug 18, 2026, covering the period ended Jun 30, 2026.
  • Where does this COSM financial data come from?
    Quantisnow builds these statements from the structured XBRL data Cosmos Health Inc. files with the SEC. It is provided for information only and is not investment advice.